Arcadia Biosciences Inc (RKDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,681 | -6,026 | -14,634 | -7,471 | 2,423 |
| Depreciation Amortization | 545 | 1,666 | 1,096 | 622 | 258 |
| Income taxes - deferred | N/A | -107 | N/A | N/A | N/A |
| Accounts receivable | 293 | -1,119 | 229 | 199 | 293 |
| Other Working Capital | -472 | -12,373 | -9,251 | -7,358 | -4,621 |
| Other Operating Activity | -6,754 | -12,259 | -907 | -2,540 | -7,623 |
| Operating Cash Flow | $-4,707 | $-30,218 | $-23,467 | $-16,548 | $-9,270 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | -1,292 | -1,292 | -1,292 | -1,292 |
| PPE Investments | -485 | -2,327 | -2,030 | -1,749 | -778 |
| Net Acquisitions | N/A | 2,653 | -500 | N/A | N/A |
| Sale Of Investment | N/A | 18,250 | 18,250 | 17,650 | 15,200 |
| Investing Cash Flow | $-485 | $17,284 | $14,428 | $14,609 | $13,130 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 3,108 | 3,108 | 3,108 | N/A |
| Debt Repayment | -2,009 | -34 | -26 | -15 | -7 |
| Common Stock Issued | 25,168 | 17,423 | 9,423 | 6,836 | 14 |
| Other Financing Activity | -1,162 | 63 | 319 | 588 | 689 |
| Financing Cash Flow | $21,997 | $20,560 | $12,824 | $10,517 | $696 |
| Beginning Cash Position | 16,043 | 8,417 | 8,417 | 8,417 | 8,417 |
| End Cash Position | 32,848 | 16,043 | 12,202 | 16,995 | 12,973 |
| Net Cash Flow | $16,805 | $7,626 | $3,785 | $8,578 | $4,556 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,707 | -30,218 | -23,467 | -16,548 | -9,270 |
| Capital Expenditure | -485 | -2,335 | -2,038 | -1,749 | -778 |
| Free Cash Flow | -5,192 | -32,553 | -25,505 | -18,297 | -10,048 |